Kraton Performance Polymers, Inc.
) has announced its plans to showcase its Cariflex polyisoprene
products and Kraton ERS polymers at the MD&M West trade show.
The show will be held at the Anaheim Convention Center, in
Anaheim, Calif. in February 2013.
The Cariflex polyisoprene products are an alternative to natural
rubber. Kraton will demonstrate how these products are better
alternative to natural rubber and are suitable for applications
that require extreme purity, exceptional protection, comfort, and
consistently high quality. Cariflex products are also used in
medical markets, where they act as a substitute for natural
rubber. They protect the physicians, nurses, and patients from
the natural rubber proteins, which are present in natural rubber,
thus saving them from the risk of Type I allergic reactions.
Kraton's ERS product line is an alternative to Polyvinyl chloride
(PVC) in medical applications. These products are extremely pure
and durable and also display low extractable performance, which
is at par with the medical industry standards. They also
provide a phthalate-free and plasticizer-free formulation that do
not disrupt the environment, but maintain the quality of the
Kraton is a leading global producer of engineered polymers used
to enhance the performance of products. The company also
invented styrenic block copolymer (SBC) chemistry and its
portfolio also consists of value-enhancing polymers that are used
in a wide variety of applications.
Kraton released its third-quarter 2012 results in October 2012.
The company posted a net loss of 48 cents per share compared with
a profit of $1.33 per share in the year-ago quarter. The results
include impairment charges and the impact related to changes in
the company's valuation allowance. Revenues decreased 14.8% year
over year to $342.6 million in the quarter.
Kraton currently retains a short-term Zacks Rank #4 (Sell).
), which also belongs to the specialty chemical industry, also
holds a Zacks Rank #4 (Sell).
KRATON PERFORM (KRA): Free Stock Analysis
POLYONE CORP (POL): Free Stock Analysis
To read this article on Zacks.com click here.